
usd feb pm et
summari compani largest pharmaci health care provid
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
feb pm stock trade
earli began test first
remodel store healthhub texa
store expand health care
servic offer aim help patient
avoid hospit better manag
health upon initi success healthhub
model announc intent
expand healthhub metro area
locat
also encourag cvss effort
drive engag custom
nationwid expans carepass
subscript program clinic trial cvss
launch expect late text
debt taken merger
suspend share repurchas program
dividend increas compani
achiev leverag ratio debt trail
ebitda near commit
lower leverag end
strong free cash flow
gener estim cvss leverag ratio
decemb
expect adjust oper incom
improv billion margin
vs
believ share trade
ep under-valued
late trade low-end
price-to-earnings rang
multitud anticip headwind
fail materi rebat
elimin think cvs-aet
combin tremend upsid potenti
aet grow exposur
medicar advantag plan grew
industri averag redesign
in-stor experi pharmaci custom
grow array health care servic
offer also reassur see
recent nimbl address popular
cost believ continu
acceler next year
growth
risk recommend price includ
integr difficulti failur improv
patient care increas industri regul
target appli forward
price-to-earnings multipl ep
risk assess reflect compani leadership
posit strong market share rel stabl
 retail drug industri pharmaci benefit
manag pbm somewhat off-set
acquisition-integr risk elev debt level
growth non-tradit competitor
fiscal year end dec ep estim base cfra
oper earn histor earn report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
gener counsel
corpor overview health corpor oper one largest drug store chain
pharmaci benefit manag base revenu net incom store count drug store offer
prescript drug wide assort gener merchandis includ over-the-counter drug beauti product
cosmet film photo finish servic season merchandis greet card conveni
servic plan design administr formulari manag claim process report
segment retail/ltc long-term care segment pharmaci servic segment pbm
acquisit insur aetna aet also oper one largest insur
 fall health benefit hcb segment establish acquisit
aet acquisit aet also result silverscript busi move hcb segment
acquir pharmaci oper aet consolid pharmaci servic busi
market profil decemb oper retail locat approxim
walk-in health care clinic lead pharmaci benefit manag million plan
member oper state district columbia puerto rico brazil fill
billion prescript billion fill retail/ltc segment account
 retail pharmaci market
pharmaci servic segment provid full rang pharmaci benefit manag pbm servic
includ oper mail order pharmaci specialti pharmaci medicar part servic
formulari manag discount drug purchas agreement busi gener billion
sale billion oper incom part pharmaci servic segment
specialti pharmaci busi oper retail specialti pharmaci store specialti mail order
pharmaci mail servic pharmaci
retail/ltc segment gener revenu billion oper incom million
retail/ltc segment revenu compris pharmaci retail segment revenu
front store revenu front store categori includ over-the-count
drug beauti product cosmet person care product conveni food among
product proprietari brand product account approxim compani front store
revenu also one largest oper retail health care clinic clinic
diagnos treat minor health condit perform health screen monitor chronic condit
hcb segment lead health care benefit provid serv estim million
peopl decemb health benefit segment offer broad rang tradit
voluntari consumer-direct health insur product relat servic includ medic
pharmaci dental behavior health medic manag capabl medicar advantag medicar
administr servic health inform technolog hit product servic
corpor strategi pharmaci servic busi strategi center provid innov tool
strategi well qualiti client servic help improv clinic outcom client plan
member assist better pharmaci manag overal health care cost aim
leverag expertis core pbm servic includ plan design offer administr
formulari manag medicar part servic mail order specialti pharmaci infus servic
diseas manag servic medic spend manag
earli began test first remodel store healthhub texa store
expand health care servic offer aim help patient avoid hospit better manag
health upon initi success healthhub model announc intent
expand healthhub metro area locat end
one key retail pharmaci busi strategi technolog allow focu
constantli improv servic explor way provid person product offer
servic continu leverag digit tool empow custom patient make full
breadth health care pharmaci servic avail anytim anywher also continu
introduc digit tool make easier peopl save time money live healthier live
roll pay nationwid end-to-end mobil payment solut integr
payment prescript pick-up extracar loyalti program one spot checkout
impact major develop agre acquir third largest health insur
aetna aet total enterpris valu billion decemb combin close
late make strateg sens us provid greater abil incent aetna larg
popul health plan particip util caremark mail order system retail store
financi trend sale grew five-year compound annual growth rate compound-annual-growth-rate
billion year end decemb adjust ep grew slightli higher five-year compound-annual-growth-rate
free cash flow measur cash flow oper less capit expenditur billion
billion billion septemb net
debt capit ratio expect compani focu reduc immens free
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
slightli overvalu usd
neutral sinc januari technic indic
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
outlook health care servic
sub-industri next year neutral
think rise wage increas
low unemploy
support stabl growth demand health care
low septemb
remain near recent month even
econom condit weaken
grow possibl expect demand
health care servic remain steadi rel
mani industri
import health care consum
hand see threat headwind
profit health care servic
industri rise wage pressur labor
shortag reimburs pressur
rise health care spend incent
legisl regul find way
control cost health care servic
industri easi target cost
cut exampl initi lower
chang payment model dialysi treatment
recent bipartisan effort tackl surpris
bill unclear chang
dialysi payment affect firm like davita
long-run forecast surpris
bill legisl like hurt physician
outsourc group limit
time see opportun
health care servic firm make best
recent headwind exampl major pbm
merg major insur off-set
pressur notabl
acquir aetna aet ci acquir
express script esrx anoth exampl
opportun evid lab servic firm
respons continu signific
provid opportun acquir
smaller lab gain scale smaller
lab like falter diminish
also see risk investor sentiment
relat certain headlin discuss
medicar type health care
system fade among democrat
candid think could still
talk point elect
would hurt investor sentiment even
littl chanc becom realiti
next sever year think realiti
would hurt health care servic
would like lead lower averag
struck individu mandat
associ afford act
howev court avoid determin
much remain valid think
outcom remov possibl
worst-cas scenario health care servic
firm complet
gener benefit increas
insur coverag past sever year
elimin certain provis
could hurt industri howev
opinion unlik case
anticip industri ep growth
estim growth rate
 health
servic gain vs increas
 health servic index
increas vs decreas
base index
five-year market price perform feb
note sector sub-industri inform base
past perform indic futur perform
reli upon
laboratori corpor america
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
news trump administr end pursuit elimin rebat
collect pbm mostli pass insur expect
elimin rebat sever impact profit pbm
move would certainli caus short-term industri friction
compani would modifi contract process respons
possibl rebat elimin also seem weigh heavili share
pbm past year on-going debat rise health care price
drug industri frequent point pbm industri key sourc
high drug price rebat elimin tabl expect trump
administr turn focu away pbm back toward drug
pm et cfra rais sector overweight
marketweight cfra rais
sector overweight marketweight market valuat
expand sector trade discount histor averag cfra
find opportun within health care sector trade forward
price-to-earnings basi histor averag first quarter
compani health care sector beat sale
earn estim best perform index biotech
pharmaceut compani account market capit
sector drug pipelin approv time reduct activ make
industri attract care histori outperform
season slow period year may octob cfra
forecast sector like disappoint lindsey bell
analyst research note compani news
et cfra keep strong buy opinion share
corpor lift target price
base multipl ep estim ep
vs higher estim lower ep
initi ep adjust oper
incom billion slightli expect revenu
billion almost billion higher expect meanwhil
cvss guidanc mostli line outlook compani
on-track better achiev promis integr synergi enterpris
modern benefit debt paydown leverag ratio debt ttm
ebitda low estim cvss leverag
ratio continu remain convinc cvss
long-term valu proposit support compani transform
progress far includ new offer rxzero addit
higher util cvss health care servic digit offer
et cfra reiter strong buy opinion share
corpor rais target price
base multipl ep ep
vs exceed estim primarili due net realiz capit
gain favor prior year develop lift ep
lower ep overal
strong quarter support posit long-term outlook share
adjust oper incom billion expect yoy
debt paydown progress faster anticip compani
repaid billion net debt sinc acquisit aetna vs
expect billion paid eight month
healthhub test houston store outperform
control group term prescript volum front store sale foot
traffic margin increas confid plan rapidli
roll-out healthhub across /kevin huang cfa
et cfra lower opinion health marketweight
overweight lower recommend exposur
sector marketweight overweight group tradit
perform well tradit lacklust summer month keep
pace overal market remaind year besid alreadi
trade elev valuat particularli best perform
sub-industri medic technolog life scienc tool think
group contend increas political/regulatori risk
presidenti elect cycl get full swing final group
below-averag percentag favor constitu invest recommend
et cfra maintain strong buy opinion share
corpor rais target base
multipl ep ep vs
surpass expect due broad-bas out-performance lift
ep pharmaci servic pbm
retail/ltc segment benefit stronger-than-expect prescript
volum growth brand name drug price inflat partial off-set
continu price/reimburs pressur gener drug usag oper
incom health care benefit segment billion
expect remain encourag effort drive higher consum
engag medic adher share retail pharmaci
market expand basi point yoy recent initi
healthhub pilot store carepass program given compani
integr progress expect million synergi ahead
initi expect million /kevin huang cfa
et cfra maintain strong buy opinion share
corpor share pharmaci benefit manag pbm
includ ci insur trade pre-market today
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
redistribut reproduct prohibit without prior written permiss copyright cfra
